Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present paper deals with the development of an immunofluorescence procedure that allows specific localization of
vasopressin
and oxytocin in the hypothalamo-
neurohypophyseal
system(hnx) of the rat. Antibodies against arginine vasopressin (AVP), lysine-
vasopressin
(LVP) and oxytocin were raised by injecting these hormones that were covalently bound to thyroglobulin into rabbits. The
vasopressin
-immunized rabbits showed periods of diabetes insipidus, while histoloty of the "hns revealed an intact neurosecretory system with signs of increased endogenous hormone synthesis in the supraoptic nucleus and increased release in the neuro-hypophysis of some rabbits. The daily water intake of the oxytocin-immunized rabbits was similar to that of control rabbits. The development of antibodies against
vasopressin
as measured in the immunofluorescence procedure showed a course that was quite different from the curve of the titer as determined by radioimmunoassay (RIA). Also the specificity of the antibodies used in the immunofluorescence procedure was found to be quite different from their specificity in a RIA system. Potency and specificity of the antibodies have to be studied therefore within the immunofluorescence procedure itself. Using freshly frozen acetone-postfixed hypotalami or pituitaries, no sharp localization of immunofluorescence could be obtained in the
HNS
. Therefore prefixation was performed. Both, the type and the duration of prefixation revealed quite different results regarding the immunofluorescence in the neurosecretory cell boides in the hypotalamus and of their endings in the neurohypophysis. The best immunofluorescence results were obtained using 6 hours glyoxal-prefixation for the hypothalamus and 24 hours formalin-prefixation for the pituitary. The cross-reaction of the antibodies for oxytocin or
vasopressin
was tested on synthetic hormones that were bound to CNBR-activated agarose beads and mounted on glass sides. All anti-plasmas showed cross-reaction on beads containing the heterologou- antigen. The plasmas were purified by incubation with beads containing the heterologous hormone until the cross-reacting component had been removed. Using purified antibodies, the distribution of oxytocin and
vasopressin
cells within the
HNS
was investigated. More oxytocin containing cells were localized in the rostral part and more
vasopressin
in the caudal part of both, the supraoptic (SON) and paraventricular nucleus (PVN). Comparable percentages of oxytocin and
vasopressin
containing cells were found in the SON and PVN. The absolute amount of oxytocin containing cells was 2.5 times more in the SON than in the PVN, which seems to contradict the "classical" view that the PVN predominantly or entirely synthetizes oxytocin. In addition, fluorescence was found using antobodies against
vasopressin
in the suprachiasmatic nucleus in Wistar rats and heterozygous Brattleboro rats, but not in this nucleus of homozygous Brattleboros.
...
PMID:Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophypopseal system. 110 Jul 84
The research reviewed in the present paper indicates that
vasopressin
and oxytocin cells in the human
HNS
constitute an extremely stable population of neurons throughout the human life span. Increases in the activity of these cells, which are probably related to maturation of the system were observed during fetal development and probably extend well beyond term. During senescence an increase in the activity of the
vasopressin
cells in the human
HNS
was observed which is probably a compensation for age-related changes in kidney function. These data do not support a role of declining
vasopressin
secretion in age-related memory decline. Although there is some evidence for an impairment of
vasopressin
synthesis and release in Alzheimer patients,
vasopressin
cell numbers in Alzheimer's disease do not fall below values observed in young controls. Furthermore, peripheral administration of
vasopressin
or
vasopressin
analogues to AD patients have not yielded consistent results.
...
PMID:The human hypothalamo-neurohypophyseal system in relation to development, aging and Alzheimer's disease. 148 Jul 51